Nalaganje...
Minimal residual disease and stem cell transplantation outcomes
Risk classification and tailoring of treatment are essential for improving outcome for patients with acute myeloid leukemia or high-risk myelodysplastic syndrome. Both patient and leukemia-specific characteristics assessed using morphology, cytogenetics, molecular biology, and multicolor flow cytome...
Shranjeno v:
| izdano v: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913494/ https://ncbi.nlm.nih.gov/pubmed/31808862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000006 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|